Anavex Life Sciences
AVXL
#7563
Rank
โ‚ฌ0.33 B
Marketcap
3,78ย โ‚ฌ
Share price
-1.12%
Change (1 day)
-47.36%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ9.85 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are โ‚ฌ9.85 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚ฌ13.74 M16.07%
2023-09-30โ‚ฌ11.83 M13.41%
2022-09-30โ‚ฌ10.43 M11.89%
2021-09-30โ‚ฌ9.32 M49.75%
2020-09-30โ‚ฌ6.23 M34.75%
2019-09-30โ‚ฌ4.62 M38.13%
2018-09-30โ‚ฌ3.34 M9.65%
2017-09-30โ‚ฌ3.05 M7.24%
2016-09-30โ‚ฌ2.84 M19.52%
2015-09-30โ‚ฌ2.38 M-58%
2014-09-30โ‚ฌ5.67 M168.48%
2013-09-30โ‚ฌ2.11 M-6.33%
2012-09-30โ‚ฌ2.25 M127.46%
2011-09-30โ‚ฌ0.99 M-58.95%
2010-09-30โ‚ฌ2.41 M-17.83%
2009-09-30โ‚ฌ2.93 M79.16%
2008-09-30โ‚ฌ1.64 M404.93%
2007-09-30โ‚ฌ0.32 M1368.75%
2006-09-30โ‚ฌ0.02 M-1.53%
2005-09-30โ‚ฌ0.02 M1013.37%
2004-09-30โ‚ฌ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ0.45 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.71 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ0.16 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ8.68 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA